409A Valuation Case Study: How a Healthcare SaaS Startup Determined Fair Market Value for Stock Options”
- 409A Valuation
- Healthcare SaaS Startup
- Delaware, United States
Introduction
For venture-backed startups in the United States, issuing employee stock options is a powerful tool to attract and retain talent. However, before granting stock options, companies must determine the Fair Market Value (FMV) of their common stock to comply with Internal Revenue Code (IRC) Section 409A.
A properly conducted 409A valuation protects both the company and its employees from significant tax penalties while providing a defensible strike price for stock option grants. Startups typically rely on an independent third-party valuation firm to perform this analysis in accordance with IRS and professional valuation standards.
This case study illustrates how Transaction Capital LLC (TXN Capital LLC) performed an IRS-compliant 409A valuation for a high-growth healthcare SaaS startup. The engagement demonstrates how professional valuation methodologies can determine the fair market value of common stock in complex venture-backed capital structures.
Client Overview
A U.S.-based healthcare technology startup engaged Transaction Capital LLC to perform an independent 409A valuation of its common stock for equity compensation compliance.
The company develops cloud-based Quality Management System (QMS) software for medical device manufacturers, helping clients streamline regulatory compliance, product lifecycle management, and operational quality processes.
The platform operates under a subscription-based SaaS model, generating recurring revenue from enterprise and mid-market healthcare clients.
Business Challenge
The company planned to issue stock options to employees and advisors as part of its long-term incentive plan. To remain compliant with Internal Revenue Code Section 409A, the company required an independent third-party valuation to determine the Fair Market Value (FMV) of its common stock.
Failure to comply with 409A regulations can lead to:
- Immediate taxation of option holders
- Additional IRS penalties
- Interest charges on deferred compensation
Therefore, obtaining a defensible 409A valuation report is critical before issuing stock options.
Several factors made the valuation complex:
Engagement Objectives
Transaction Capital LLC was engaged to:
- Determine the Fair Market Value of common stock under IRC Section 409A
- Establish a defensible strike price for employee stock option grants
- Ensure IRS Safe Harbor compliance
- Provide a valuation report acceptable to auditors, investors, and legal advisors
Valuation Methodology
The valuation was conducted in accordance with:
- IRS Revenue Ruling 59-60
- AICPA valuation guidelines
- USPAP (Uniform Standards of Professional Appraisal Practice)
- NACVA professional valuation standards
Methods Considered but Not Applied
Subject Company Transaction Method (SCTM)
The Subject Company Transaction Method was considered but not applied because no recent arm’s-length transactions in the company’s common stock occurred near the valuation date.
The last funding round occurred approximately three years earlier at a deferred valuation, and given the company’s substantial growth since then, that transaction was not considered a reliable or representative benchmark for the current valuation.
Asset-Based Approach
The Asset-Based Approach was considered but not applied because the company operates as a going-concern SaaS business with significant growth prospects and substantial intangible assets, including proprietary software and customer relationships.
This approach is generally more appropriate for asset-intensive or distressed businesses, and therefore was not considered suitable for the subject company.
Discount Rate Determination
The discount rate used in the DCF analysis was estimated using the Weighted Average Cost of Capital (WACC) approach.
Key inputs included:
- Risk-free rate based on the 20-Year U.S. Treasury yield
- Equity risk premium (ERP)
- Size premium
- Company-specific risk premium (CSRP)
- Industry-adjusted beta reflecting the company’s early-stage risk profile
- Company borrowing rate
- Industry capital structure benchmarks
Financial Statement Adjustments
Certain financial adjustments were considered to normalize the company’s financial statements. As the subject company operates as an LLC, a normalized blended federal and state tax rate was applied in the valuation analysis to reflect the tax treatment applicable to a market participant acquiring the business.
Equity Allocation Model
Because the company had multiple classes of securities, an Option Pricing Model (OPM) was used to allocate enterprise value among preferred and common equity.
This model incorporates:
- Investor liquidation preferences
- Capital structure complexity
- Potential future exit scenarios
This model ensures that the fair market value of common stock appropriately reflects the economic rights of preferred shareholders.
Marketability Discount
Since the company’s shares are privately held and not freely tradable, a Discount for Lack of Marketability (DLOM) was applied to reflect the illiquid nature of startup equity.
Valuation Conclusion
Following the application of the income and market approaches, and after allocating value across equity classes using the Option Pricing Model, Transaction Capital LLC concluded the Fair Market Value of the company’s common stock on a minority, non-marketable basis for purposes of IRC Section 409A compliance.
The resulting valuation enabled the company to establish a defensible strike price for employee stock option grants while maintaining IRS Safe Harbor protection.
